The DOI matches its Crossref record; 212 of the 212 references it cites were found in a registry or an index.
Modulation of Protein–Protein Interactions with Small Organic Molecules
Abstract
Many proteins exert their biological roles as components of complexes, and the functions of proteins are often determined by their specific interactions with other proteins. Because of the central importance of protein–protein interactions for cellular processes, the ability to interfere with specific protein–protein interactions provides a powerful means of influencing the function of selected proteins within the cell. Cell‐permeable small organic modulators of protein–protein interactions are thus highly desirable tools both for the study of physiological cellular processes and for the treatment of numerous diseased states. Herein a number of protein–protein interactions that are considered to be pharmaceutical targets are presented, which will familiarize the reader with the strategies that have been employed for the successful identification of small molecule modulators of these protein–protein interactions. These encouraging examples suggest that combined research efforts in the areas of functional proteomics, assay development, and organic synthesis will open up novel possibilities for the treatment of human diseases in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Zwischenmolekulare Energiewanderung und Fluoreszenz
Förster, T. (1948) · Annalen der Physik · doi:10.1002/andp.19484370105 · Cited by 8,285
The L-Arginine-Nitric Oxide Pathway
Epstein, F. H., Moncada, S., & Higgs, A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292706 · Cited by 6,678
The interpretation of protein structures: Estimation of static accessibility
Lee, B., & Richards, F. M. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90324-x · Cited by 5,850
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Functional organization of the yeast proteome by systematic analysis of protein complexes
Gavin, A.-C., Bösche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A., Schultz, J., Rick, J. M., Michon, A.-M., Cruciat, C.-M., et al. (2002) · Nature · doi:10.1038/415141a · Cited by 4,759
Nitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
The Metabolic Basis of Inherited Disease
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-5-389_2 · Cited by 3,983
Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry
Ho, Y., Gruhler, A., Heilbut, A., Bader, G. D., Moore, L., Adams, S.-L., Millar, A., Taylor, P., Bennett, K., Boutilier, K., et al. (2002) · Nature · doi:10.1038/415180a · Cited by 3,601
Principles of protein-protein interactions
Jones, S., & Thornton, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.13 · Cited by 2,684
Mechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
Human Growth Hormone and Extracellular Domain of Its Receptor: Crystal Structure of the Complex
de Vos, A. M., Ultsch, M., & Kossiakoff, A. A. (1992) · Science · doi:10.1126/science.1549776 · Cited by 2,239
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Discovering High-Affinity Ligands for Proteins: SAR by NMR
Shuker, S. B., Hajduk, P. J., Meadows, R. P., & Fesik, S. W. (1996) · Science · doi:10.1126/science.274.5292.1531 · Cited by 2,041
Anatomy of hot spots in protein interfaces
Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988
A Hot Spot of Binding Energy in a Hormone-Receptor Interface
Clackson, T., & Wells, J. A. (1995) · Science · doi:10.1126/science.7529940 · Cited by 1,983
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht
Conte, L. L., Chothia, C., & Janin, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2439 · Cited by 1,964
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Signal transduction by tumor necrosis factor and its relatives
Baud, V., & Karin, M. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02064-5 · Cited by 1,655
Dimerization of cell surface receptors in signal transduction
Heldin, C.-H. (1995) · Cell · doi:10.1016/0092-8674(95)90404-2 · Cited by 1,634
Alberts, A. W., Chen, J., Kuron, G., Hunt, V, Huff, J., Hoffman, C., Rothrock, J., Lopez, M., Joshua, H., Harris, E., et al. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3957 · Cited by 1,628
Brooks, P. C., Strömblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., & Cheresh, D. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81235-0 · Cited by 1,552
Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis
Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J., et al. (1997) · Science · doi:10.1126/science.275.5302.983 · Cited by 1,476
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S.-L., et al. (1996) · Nature · doi:10.1038/381335a0 · Cited by 1,467
Active human immunodeficiency virus protease is required for viral infectivity
Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., & Sigal, I. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4686 · Cited by 1,307
Wang, J.-L., Liu, D., Zhang, Z.-J., Shan, S., Han, X., Srinivasula, S. M., Croce, C. M., Alnemri, E. S., & Huang, Z. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7124 · Cited by 1,201
Erythropoietin: structure, control of production, and function
Jelkmann, W. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.2.449 · Cited by 1,151
Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Marmer, B. L., Grant, G. A., Seltzer, J. L., Kronberger, A., He, C. S., Bauer, E. A., & Goldberg, G. I. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68680-6 · Cited by 1,044
Weitz-Schmidt, G., Welzenbach, K., Brinkmann, V., Kamata, T., Kallen, J., Bruns, C., Cottens, S., Takada, Y., & Hommel, U. (2001) · Nature Medicine · doi:10.1038/89058 · Cited by 1,041
Regulation of p53 in response to DNA damage
Lakin, N. D., & Jackson, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203015 · Cited by 987
Inducible nitric oxide synthase: what difference does it make?
Nathan, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119782 · Cited by 943
Automated docking with grid‐based energy evaluation
Meng, E. C., Shoichet, B. K., & Kuntz, I. D. (1992) · Journal of Computational Chemistry · doi:10.1002/jcc.540130412 · Cited by 938
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
Little, C. D., Nau, M. M., Carney, D. N., Gazdar, A. F., & Minna, J. D. (1983) · Nature · doi:10.1038/306194a0 · Cited by 920
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
Navia, M. A., Fitzgerald, P. M. D., McKeever, B. M., Leu, C.-T., Heimbach, J. C., Herber, W. K., Sigal, I. S., Darke, P. L., & Springer, J. P. (1989) · Nature · doi:10.1038/337615a0 · Cited by 894
Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CD18)
Lee, J.-O., Rieu, P., Arnaout, M. A., & Liddington, R. (1995) · Cell · doi:10.1016/0092-8674(95)90517-0 · Cited by 887
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Felsher, D. W., & Bishop, J. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80367-6 · Cited by 881
Krantz, S. (1991) · Blood · doi:10.1182/blood.v77.3.419.419 · Cited by 855
Controlling Signal Transduction with Synthetic Ligands
Spencer, D. M., Wandless, T. J., Schreiber, S. L., & Crabtree, G. R. (1993) · Science · doi:10.1126/science.7694365 · Cited by 843
Gohlke, H., & Klebe, G. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020802)41:15<2644::aid-anie2644>3.0.co;2-o · Cited by 843
N -Methylated Cyclic RGD Peptides as Highly Active and Selective α V β 3 Integrin Antagonists
Dechantsreiter, M. A., Planker, E., Mathä, B., Lohof, E., Hölzemann, G., Jonczyk, A., Goodman, S. L., & Kessler, H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm970832g · Cited by 838
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Interaction between CD4 and class II MHC molecules mediates cell adhesion
Doyle, C., & Strominger, J. L. (1987) · Nature · doi:10.1038/330256a0 · Cited by 821
Intercellular adhesion molecule-1
van de Stolpe, A., & van der Saag, P. T. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00202069 · Cited by 802
Van Seventer, G. A., Shimizu, Y., Horgan, K. J., & Shaw, S. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.12.4579 · Cited by 783
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
INTERACTIONS BETWEEN DEOXYRIBONUCLEOTIDE AND DNA SYNTHESIS
Reichard, P. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002025 · Cited by 779
Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain
Ferré-D'Amaré, A. R., Prendergast, G. C., Ziff, E. B., & Burley, S. K. (1993) · Nature · doi:10.1038/363038a0 · Cited by 724
Miller, M., Schneider, J., Sathyanarayana, B. K., Toth, M. V., Marshall, G. R., Clawson, L., Selk, L., Kent, S. B. H., & Wlodawer, A. (1989) · Science · doi:10.1126/science.2686029 · Cited by 684
Convergent Solutions to Binding at a Protein-Protein Interface
DeLano, W. L., Ultsch, M. H., de, A. M., Vos, & Wells, J. A. (2000) · Science · doi:10.1126/science.287.5456.1279 · Cited by 672
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Converting a Peptide into a Drug: Strategies to Improve Stability and Bioavailability
Adessi, C., & Soto, C. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606731 · Cited by 614
Lai, Z., Colón, W., & Kelly, J. W. (1996) · Biochemistry · doi:10.1021/bi952501g · Cited by 574
Oncogenic activity of the c-Myc protein requires dimerization with Max
Amati, B., Brooks, M. W., Levy, N., Littlewood, T. D., Evan, G. I., & Land, H. (1993) · Cell · doi:10.1016/0092-8674(93)90663-b · Cited by 560
Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains
Wang, J., Yan, Y., Garrett, T. P. J., Liu, J., Rodgers, D. W., Garlick, R. L., Tarr, G. E., Husain, Y., Reinherz, E. L., & Harrison, S. C. (1990) · Nature · doi:10.1038/348411a0 · Cited by 558
Crystal structure of an HIV-binding recombinant fragment of human CD4
Ryu, S.-E., Kwong, P. D., Truneh, A., Porter, T. G., Arthos, J. A., Rosenberg, M. J., Dai, X., Xuong, N., Axel, R., Sweet, R. W., et al. (1990) · Nature · doi:10.1038/348419a0 · Cited by 552
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550
A humanized system for pharmacologic control of gene expression
Rivera, V. M., Clackson, T., Natesan, S., Pollock, R., Amara, J. F., Keenan, T., Magari, S. R., Phillips, T., Courage, N. L., Cerasoli, F., et al. (1996) · Nature Medicine · doi:10.1038/nm0996-1028 · Cited by 534
Comparison of a Structural and a Functional Epitope
Cunningham, B. C., & Wells, J. A. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1611 · Cited by 510
Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization
Koury, S., Bondurant, M., & Koury, M. (1988) · Blood · doi:10.1182/blood.v71.2.524.524 · Cited by 477
Breinbauer, R., Vetter, I. R., & Waldmann, H. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020816)41:16<2878::aid-anie2878>3.0.co;2-b · Cited by 475
Reversible Activation of c-Myc in Skin
Pelengaris, S., Littlewood, T., Khan, M., Elia, G., & Evan, G. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80350-0 · Cited by 468
Site-directed ligand discovery
Erlanson, D. A., Braisted, A. C., Raphael, D. R., Randal, M., Stroud, R. M., Gordon, E. M., & Wells, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9367 · Cited by 466
Solution structure of the antiapoptotic protein bcl-2
Petros, A. M., Medek, A., Nettesheim, D. G., Kim, D. H., Yoon, H. S., Swift, K., Matayoshi, E. D., Oltersdorf, T., & Fesik, S. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041619798 · Cited by 458
Brefeldin A Acts to Stabilize an Abortive ARF–GDP–Sec7 Domain Protein Complex
Peyroche, A., Antonny, B., Robineau, S., Acker, J., Cherfils, J., & Jackson, C. L. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80455-4 · Cited by 453
Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3
Tzung, S.-P., Kim, K. M., Basañez, G., Giedt, C. D., Simon, J., Zimmerberg, J., Zhang, K. Y. J., & Hockenbery, D. M. (2001) · Nature Cell Biology · doi:10.1038/35055095 · Cited by 452
Taxol and taxotere: discovery, chemistry, and structure-activity relationships
Guenard, D., Gueritte-Voegelein, F., & Potier, P. (1993) · Accounts of Chemical Research · doi:10.1021/ar00028a005 · Cited by 444
HIV-1 Protease Inhibitors: A Review for Clinicians
Deeks, S. G. (1997) · JAMA · doi:10.1001/jama.1997.03540260059037 · Cited by 434
p53-Dependent apoptosis pathways
(2001) · Advances in Cancer Research · doi:10.1016/s0065-230x(01)82002-9 · Cited by 418
Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein
Monaco, H., Rizzi, M., & Coda, A. (1995) · Science · doi:10.1126/science.7754382 · Cited by 409
Menssen, A., & Hermeking, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082005599 · Cited by 406
Synthesis of epothilones A and B in solid and solution phase
Nicolaou, K. C., Winssinger, N., Pastor, J., Ninkovic, S., Sarabia, F., He, Y., Vourloumis, D., Yang, Z., Li, T., Giannakakou, P., et al. (1997) · Nature · doi:10.1038/387268a0 · Cited by 400
Discodermolide, A Cytotoxic Marine Agent That Stabilizes Microtubules More Potently Than Taxol,
ter Haar, E., Kowalski, R. J., Hamel, E., Lin, C. M., Longley, R. E., Gunasekera, S. P., Rosenkranz, H. S., & Day, B. W. (1996) · Biochemistry · doi:10.1021/bi9515127 · Cited by 382
Murad, F. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990712)38:13/14<1856::aid-anie1856>3.0.co;2-d · Cited by 381
Rational design of potent human transthyretin amyloid disease inhibitors.
Sacchettini, J. C., Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., & Kelly, J. W. (2000) · Nature Structural Biology · doi:10.1038/74082 · Cited by 379
Nitric Oxide: A Unique Endogenous Signaling Molecule in Vascular Biology (Nobel Lecture)
Ignarro, L. J. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990712)38:13/14<1882::aid-anie1882>3.0.co;2-v · Cited by 362
Liu, G., Huth, J. R., Olejniczak, E. T., Mendoza, R. R., DeVries, P. J., Leitza, S. T., Reilly, E. B., Okasinski, G. F., Fesik, S. W., & von Geldern, T. W. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm000503f · Cited by 359
Inhibiting transthyretin amyloid fibril formation via protein stabilization
Miroy, G. J., Lai, Z., Lashuel, H. A., Peterson, S. A., Strang, C., & Kelly, J. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15051 · Cited by 344
Liao, D. J., & Dickson, R. B. (2000) · Endocrine-related cancer · doi:10.1677/erc.0.0070143 · Cited by 343
Furchgott, R. F. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990712)38:13/14<1870::aid-anie1870>3.0.co;2-8 · Cited by 334
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.
Seelmeier, S., Schmidt, H., Turk, V, & von der Helm, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6612 · Cited by 328
Berg, T., Cohen, S. B., Desharnais, J., Sonderegger, C., Maslyar, D. J., Goldberg, J., Boger, D. L., & Vogt, P. K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062036999 · Cited by 326
Self-citationActivation of the Raf-1 kinase cascade by coumermycin-induced dimerization
Farrar, M. A., Alberola-lla, J., & Perlmutter, R. M. (1996) · Nature · doi:10.1038/383178a0 · Cited by 318
Discovery of Potent Nonpeptide Inhibitors of Stromelysin Using SAR by NMR
Hajduk, P. J., Sheppard, G., Nettesheim, D. G., Olejniczak, E. T., Shuker, S. B., Meadows, R. P., Steinman, D. H., Carrera, G. M., Marcotte, P. A., Severin, J., et al. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9702778 · Cited by 317
Discovery of Small-Molecule Inhibitors of Bcl-2 through Structure-Based Computer Screening
Enyedy, I. J., Ling, Y., Nacro, K., Tomita, Y., Wu, X., Cao, Y., Guo, R., Li, B., Zhu, X., Huang, Y., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010016f · Cited by 315
Fluorescence Polarization and Anisotropy in High Throughput Screening: Perspectives and Primer
Owicki, J. C. (2000) · SLAS Discovery · doi:10.1177/108705710000500501 · Cited by 303
Eleutherobin, a New Cytotoxin that Mimics Paclitaxel (Taxol) by Stabilizing Microtubules
Lindel, T., Jensen, P. R., Fenical, W., Long, B. H., Casazza, A. M., Carboni, J., & Fairchild, C. R. (1997) · Journal of the American Chemical Society · doi:10.1021/ja9717828 · Cited by 293
Grandori, C. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01025-6 · Cited by 285
Inhibition of Protein−Protein Association by Small Molecules: Approaches and Progress
Toogood, P. L. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010468s · Cited by 281
Oblimersen Bcl-2 Antisense: Facilitating Apoptosis in Anticancer Treatment
Klasa, R. J., Gillum, A. M., Klem, R. E., & Frankel, S. R. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760220798 · Cited by 280
Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules
Gahmberg, C. G. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80117-2 · Cited by 278
Belshaw, P. J., Ho, S. N., Crabtree, G. R., & Schreiber, S. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.4604 · Cited by 278
Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53
Stoll, R., Renner, C., Hansen, S., Palme, S., Klein, C., Belling, A., Zeslawski, W., Kamionka, M., Rehm, T., Mühlhahn, P., et al. (2001) · Biochemistry · doi:10.1021/bi000930v · Cited by 275
Nitric Oxide: Chemical Puzzles Posed by a Biological Messenger
Pfeiffer, S., Mayer, B., & Hemmens, B. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990614)38:12<1714::aid-anie1714>3.0.co;2-3 · Cited by 266
Kollias, G., Douni, E., Kassiotis, G., & Kontoyiannis, D. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01315.x · Cited by 263
Silletti, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011343298 · Cited by 262
Dimeric ligands define a role for transcriptional activation domains in reinitiation
Ho, S. N., Biggar, S. R., Spencer, D. M., Schreiber, S. L., & Crabtree, G. R. (1996) · Nature · doi:10.1038/382822a0 · Cited by 261
Therapeutic strategies for human amyloid diseases
Sacchettini, J. C., & Kelly, J. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd769 · Cited by 261
Kallen, J., Welzenbach, K., Ramage, P., Geyl, D., Kriwacki, R., Legge, G., Cottens, S., Weitz-Schmidt, G., & Hommel, U. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3047 · Cited by 256
Wojtowicz-Praga, S., Torri, J., Johnson, M., Steen, V, Marshall, J., Ness, E., Dickson, R., Sale, M., Rasmussen, H. S., Chiodo, T. A., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.6.2150 · Cited by 252
Molecular characterization of the hdm2-p53 interaction 1 1Edited by J. Karn
Böttger, A., Böttger, V., Garcia-Echeverria, C., Chène, P., Hochkeppel, H.-K., Sampson, W., Ang, K., Howard, S. F., Picksley, S. M., & Lane, D. P. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1078 · Cited by 252
García-Echeverría, C., Chène, P., Blommers, M. J. J., & Furet, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990966p · Cited by 246
Peters, K. P., Fauck, J., & Frömmel, C. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0077 · Cited by 243
Erisman, M. D., Rothberg, P. G., Diehl, R. E., Morse, C. C., Spandorfer, J. M., & Astrin, S. M. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.8.1969 · Cited by 238
Antagonists of protein–protein interactions
Cochran, A. G. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00106-x · Cited by 228
Jacobson, J. G., Leib, D. A., Goldstein, D. J., Bogard, C. L., Schaffer, P. A., Weller, S. K., & Coen, D. M. (1989) · Virology · doi:10.1016/0042-6822(89)90244-4 · Cited by 227
Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding
Clayton, L. K., Sieh, M., Pious, D. A., & Reinherz, E. L. (1989) · Nature · doi:10.1038/339548a0 · Cited by 223
Liu, G., Link, J. T., Pei, Z., Reilly, E. B., Leitza, S. T., Nguyen, B., Marsh, K. C., Okasinski, G. F., von Geldern, T. W., Ormes, M., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002782 · Cited by 220
Preclinical and Clinical Studies of MMP Inhibitors in Cancer
DRUMMOND, A. H., BECKETT, P., BROWN, P. D., BONE, E. A., DAVIDSON, A. H., GALLOWAY, W. A., GEARING, A. J. H., HUXLEY, P., LABER, D., MCCOURT, M., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07688.x · Cited by 219
Review: Modulating Factors in Amyloid-β Fibril Formation
McLaurin, J., Yang, D.-S., Yip, C. M., & Fraser, P. E. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4289 · Cited by 218
A versatile synthetic dimerizer for the regulation of protein–protein interactions
Amara, J. F., Clackson, T., Rivera, V. M., Guo, T., Keenan, T., Natesan, S., Pollock, R., Yang, W., Courage, N. L., Holt, D. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10618 · Cited by 206
Inhibiting transthyretin conformational changes that lead to amyloid fibril formation
Peterson, S. A., Klabunde, T., Lashuel, H. A., Purkey, H., Sacchettini, J. C., & Kelly, J. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.12956 · Cited by 206
McMillan, K., Adler, M., Auld, D. S., Baldwin, J. J., Blasko, E., Browne, L. J., Chelsky, D., Davey, D., Dolle, R. E., Eagen, K. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1506 · Cited by 201
Taga, T., Suzuki, A., Gonzalez‐Gomez, I., Gilles, F. H., Stins, M., Shimada, H., Barsky, L., Weinberg, K. I., & Laug, W. E. (2002) · International Journal of Cancer · doi:10.1002/ijc.10265 · Cited by 198
Nanomolar Small Molecule Inhibitors for αvβ6, αvβ5, and αvβ3 Integrins
Goodman, S. L., Hölzemann, G., Sulyok, G. A. G., & Kessler, H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0102598 · Cited by 196
p53-Dependent cell cycle control: response to genotoxic stress
Schwartz, D., & Rotter, V. (1998) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0095 · Cited by 195
A ligand-reversible dimerization system for controlling protein–protein interactions
Rollins, C. T., Rivera, V. M., Woolfson, D. N., Keenan, T., Hatada, M., Adams, S. E., Andrade, L. J., Yaeger, D., van Schravendijk, M. R., Holt, D. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100101997 · Cited by 190
Maly, D. J., Choong, I. C., & Ellman, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2419 · Cited by 189
Nitric oxide and inflammatory joint diseases
Stichtenoth, D. O., & Frolich, J. C. (1998) · Rheumatology · doi:10.1093/rheumatology/37.3.246 · Cited by 180
Isolation and Structure Elucidation of Chlorofusin, a Novel p53-MDM2 Antagonist from a Fusarium sp.
Duncan, S. J., Grüschow, S., Williams, D. H., McNicholas, C., Purewal, R., Hajek, M., Gerlitz, M., Martin, S., Wrigley, S. K., & Moore, M. (2001) · Journal of the American Chemical Society · doi:10.1021/ja002940p · Cited by 172
Gadek, T. R., Burdick, D. J., McDowell, R. S., Stanley, M. S., Marsters, J. C., Paris, K. J., Oare, D. A., Reynolds, M. E., Ladner, C., Zioncheck, K. A., et al. (2002) · Science · doi:10.1126/science.295.5557.1086 · Cited by 172
Thyroid Hormone Transport Proteins
Bartalena, L., & ROBBINS, J. J. (1993) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30427-x · Cited by 167
SH3 domains and drug design: Ligands, structure, and biological function
Dalgarno, D. C., Botfield, M. C., & Rickles, R. J. (1997) · Biopolymers · doi:10.1002/(sici)1097-0282(1997)43:5<367::aid-bip3>3.0.co;2-t · Cited by 166
The structural stability of the HIV-1 protease 1 1Edited by P. E. Wright
Todd, M. J., Semo, N., & Freire, E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2090 · Cited by 166
Über die Isolierung neuer Stoffwechselprodukte aus Penicillium brefeldianum D ODGE
Härri, E., Loeffler, W., Sigg, H. P., Stähelin, H., & Tamm, C. (1963) · Helvetica Chimica Acta · doi:10.1002/hlca.19630460419 · Cited by 162
Huth, J. R., Olejniczak, E. T., Mendoza, R., Liang, H., Harris, E. A. S., Lupher, M. L., Wilson, A. E., Fesik, S. W., & Staunton, D. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5231 · Cited by 161
Carter, P. H., Scherle, P., Muckelbauer, J. A., Voss, M. E., Liu, R., Thompson, L. A., Tebben, A. J., Solomon, K. A., Lo, Y. C., Li, Z., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211178398 · Cited by 159
Structure and expression of the human and mouse T4 genes.
Maddon, P. J., Molineaux, S. M., Maddon, D. E., Zimmerman, K. A., Godfrey, M., Alt, F. W., Chess, L., & Axel, R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9155 · Cited by 158
Pfeifer, A., Keßler, T., Silletti, S., Cheresh, D. A., & Verma, I. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.220399597 · Cited by 151
Zhang, Z., Poorman, R. A., Maggiora, L. L., Heinrikson, R. L., & Kézdy, F. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98445-0 · Cited by 150
Protein–protein interfaces: mimics and inhibitors
Cochran, A. G. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(01)00262-9 · Cited by 149
Cameron, J. M., McDougall, I., Marsden, H. S., Preston, V. G., Ryan, D. M., & Subak-Sharpe, J. H. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-10-2607 · Cited by 148
Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization
Spencer, D. M., Belshaw, P. J., Chen, L., Ho, S. N., Randazzo, F. M., Crabtree, G. R., & Schreiber, S. L. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00607-3 · Cited by 144
Fleury, S., Lamarre, D., Meloche, S., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90447-7 · Cited by 144
Hung, D. T., Chen, J., & Schreiber, S. L. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90108-8 · Cited by 141
Discovering transthyretin amyloid fibril inhibitors by limited screening
Baures, P. W., Peterson, S., & Kelly, J. W. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00130-8 · Cited by 141
Chêne, P., Fuchs, J. P., Bohn, J. A., Garcı́a-Echeverrı́a, C., Furet, P., & Fabbro, D. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3738 · Cited by 139
Cutting Edge: A Small Molecule Antagonist of LFA-1-Mediated Cell Adhesion
Kelly, T. A., Jeanfavre, D. D., McNeil, D. W., Woska, J. R., Reilly, P. L., Mainolfi, E. A., Kishimoto, K. M., Nabozny, G. H., X.-J.Zinter, R. W., Bormann, B., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5173 · Cited by 139
Baures, P. W., Oza, V. B., Peterson, S., & Kelly, J. W. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00066-8 · Cited by 135
Oza, V. B., Smith, C., Raman, P., Koepf, E. K., Lashuel, H. A., Petrassi, H. M., Chiang, K. P., Powers, E. T., Sachettinni, J., & Kelly, J. W. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010257n · Cited by 133
Last-Barney, K., Davidson, W. C., Cardozo, M. G., Frye, L. L., Grygon, C. A., Hopkins, J. L., Jeanfavre, D. D., Pav, S., Qian, C., Stevenson, J. M., et al. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0104249 · Cited by 132
A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo
Liuzzi, M., Déziel, R., Moss, N., Beaulieu, P. L., Bonneau, A.-M., Bousquet, C., Chafouleas, J. G., Garneau, M., Jaramillo, J., Krogsrud, R. L., et al. (1994) · Nature · doi:10.1038/372695a0 · Cited by 131
Anticancer therapy with novel tubulin-interacting drugs
Kavallaris, M., Verrills, N. M., & Hill, B. T. (2001) · Drug Resistance Updates · doi:10.1054/drup.2002.0230 · Cited by 129
Crystal Structure of Rat Bcl-xL
Aritomi, M., KUNISHIMA, N., Inohara, N., Ishibashi, Y., Ohta, S., & Morikawa, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27886 · Cited by 127
Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma
Purkey, H. E., Dorrell, M. I., & Kelly, J. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091431798 · Cited by 124
Lugovskoy, A. A., Degterev, A., Fahmy, A. F., Zhou, P., Gross, J. D., Yuan, J., & Wagner, G. (2002) · Journal of the American Chemical Society · doi:10.1021/ja011239y · Cited by 120
Structural Variants of Human Growth Hormone: Biochemical, Genetic, and Clinical Aspects
Chawla, R. K., Parks, J. S., & Rudman, D. R. (1983) · Annual Review of Medicine · doi:10.1146/annurev.me.34.020183.002511 · Cited by 120
The Molecular Basis for Growth Hormone–Receptor Interactions
Wells, J. A., Cunningham, B. C., Fuh, G., Lowman, H. B., Ultsch, M. H., deVos, A. M., Bass, S., & Mulkerrin, M. G. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-571148-7.50013-0 · Cited by 116
Zutshi, R., Franciskovich, J., Shultz, M. D., Schweitzer, B. A., Bishop, P. A., Wilson, M. E., & Chmielewski, J. A. (1997) · Journal of the American Chemical Society · doi:10.1021/ja962496j · Cited by 115
Lavigne, P., Crump, M. P., Gagné, S. M., Hodges, R. S., Kay, C. M., & Sykes, B. D. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1914 · Cited by 111
Inhibiting the assembly of protein—protein interfaces
Zutshi, R., Brickner, M., & Chmielewski, J. A. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80036-7 · Cited by 110
Mimicry of erythropoietin by a nonpeptide molecule
Qureshi, S. A., Kim, R. M., Konteatis, Z. D., Biazzo-Ashnault, D. E., Motamedi, H., Rodrigues, R., Boice, J. A., Calaycay, J. R., Bednarek, M. A., Griffin, P. R., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.12156 · Cited by 102
Screening Transthyretin Amyloid Fibril Inhibitors
McCammon, M. G., Scott, D. J., Keetch, C. A., Greene, L. H., Purkey, H. E., Petrassi, H. M., Kelly, J. W., & Robinson, C. V. (2002) · Structure · doi:10.1016/s0969-2126(02)00771-2 · Cited by 101
Blasko, E., Glaser, C. B., Devlin, J. J., Xia, W., Feldman, R. I., Polokoff, M. A., Phillips, G. B., Whitlow, M. D., Auld, D. S., McMillan, K., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105691200 · Cited by 101
Designing Small-Molecule Switches for Protein-Protein Interactions
Guo, Z., Zhou, D., & Schultz, P. G. (2000) · Science · doi:10.1126/science.288.5473.2042 · Cited by 93
Structural and functional basis for hormone binding and receptor oligomerization
Wells, J. A. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90132-5 · Cited by 91
Belshawl, P. J., Spencer, D. M., Crabtree, G. R., & Schreiber, S. L. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90249-5 · Cited by 89
The Pathogenicity of Ribonucleotide Reductase-Null Mutants of Herpes Simplex Virus Type 1 in Mice
Yamada, Y., Kimura, H., Morishima, T., Daikoku, T., Maeno, K., & Nishiyama, Y. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.6.1091 · Cited by 86
Anti-CD4 Monoclonal Antibody Therapy in Human Autoimmune Diseases
Schulze‐Koops, H., & Lipsky, P. E. (2000) · KARGER eBooks · doi:10.1159/000060506 · Cited by 84
Structure-Based Design of N-Phenyl Phenoxazine Transthyretin Amyloid Fibril Inhibitors
Petrassi, H. M., Klabunde, T., Sacchettini, J. C., & Kelly, J. W. (2000) · Journal of the American Chemical Society · doi:10.1021/ja993309v · Cited by 84
Welzenbach, K., Hommel, U., & Weitz‐Schmidt, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110521200 · Cited by 82
Physiological and Toxicological Actions of Nitric Oxide in the Central Nervous System
Dawson, V. L., & Dawson, T. M. (1995) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61095-9 · Cited by 81
The inhibition of human immunodeficiency virus proteases by ‘interface peptides’
Schramm, H. J., Boetzel, J., Büttner, J., Fritsche, E., Göhring, W., Jaeger, E., KONIG, S., Thumfart, J. O., Wenger, T., & NAGEL, N. (1996) · Antiviral Research · doi:10.1016/0166-3542(96)00940-0 · Cited by 79
Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors
Oza, V. B., Petrassi, H. M., Purkey, H. E., & Kelly, J. W. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00696-9 · Cited by 78
Selective GRB2 SH2 inhibitors as anti-Ras therapy
Gay, B., Suarez, S., Caravatti, G., Furet, P., Meyer, T., & Schoepfer, J. G. (1999) · International Journal of Cancer · Cited by 74
Boger, D. L., Lee, J. K., Goldberg, J., & Jin, Q. (2000) · The Journal of Organic Chemistry · doi:10.1021/jo9916481 · Cited by 74
Idowu, A. D., Fraser-Smith, E. B., Poffenberger, K. L., & Herman, R. C. (1992) · Antiviral Research · doi:10.1016/0166-3542(92)90048-a · Cited by 73
Kuner, P., Bohrmann, B., Tjernberg, L. O., Näslund, J., Huber, G., Celenk, S., Grüninger-Leitch, F., Richards, J. G., Jakob-Rœtne, R., Kemp, J. A., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1673 · Cited by 70
Cornejo, C. J., Winn, R. K., & Harlan, J. M. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60070-8 · Cited by 67
Affinity Selection from Biological Libraries
Smothers, J. F., Henikoff, S., & Carter, P. (2002) · Science · doi:10.1126/science.298.5593.621 · Cited by 67
Kaul, D. R., Cinti, S. K., Carver, P. L., & Kazanjian, P. H. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.4.281.30937 · Cited by 67
Wolff, D. J., Lubeskie, A., & Umansky, S. R. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1454 · Cited by 65
UCS15A, a novel small molecule, SH3 domain-mediated protein–protein interaction blocking drug
Oneyama, C., Nakano, H., & Sharma, S. V. (2002) · Oncogene · doi:10.1038/sj.onc.1205271 · Cited by 65
Song, L., Gao, J., Satoh, T. K., Friedman, T. M., Edling, A. E., Koch, U., Choksi, S., Han, X., Korngold, R., & Huang, Z. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.73 · Cited by 64
Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa
Tcheng, J. E., & O’Shea, J. C. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.8.1199 · Cited by 62
Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma
Gerbitz, A., Mautner, J., Geltinger, C., Hörtnagel, K., Christoph, B., Asenbauer, H., Klobeck, G., Polack, A., & Bornkamm, G. W. (1999) · Oncogene · doi:10.1038/sj.onc.1202468 · Cited by 60
A Src SH2 selective binding compound inhibits osteoclast-mediated resorption
Violette, S. M., Shakespeare, W. C., Bartlett, C., Guan, W., Smith, J. A., Rickles, R. J., Bohacek, R. S., Holt, D. A., Baron, R., & Sawyer, T. K. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00090-9 · Cited by 59
Winn, M., Reilly, E. B., Liu, G., Huth, J. R., Jae, H.-S., Freeman, J. C., Pei, Z., Xin, Z., Lynch, J., Kester, J., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0103108 · Cited by 58
UCS15A, a non-kinase inhibitor of Src signal transduction
Sharma, S. V., Oneyama, C., Yamashita, Y., Nakano, H., Sugawara, K., Hamada, M., Kosaka, N., & Tamaoki, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204296 · Cited by 58
Bohrmann, B., Adrian, M., Dubochet, J., Kuner, P., Müller, F., Huber, W., Nordstedt, C., & Döbeli, H. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4241 · Cited by 58
Murad, F. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19990712)111:13/14<1976::aid-ange1976>3.0.co;2-a · Cited by 57
A small-molecule antagonist of LFA-1 blocks a conformational change important for LFA-1 function
Woska, J. R., Shih, D.-T., Taqueti, V. R., Hogg, N., Kelly, T. A., & Kishimoto, T. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.2.329 · Cited by 56
Inhibition of HIV-1 Protease by a Subunit of Didemnaketal A
Fan, X., Flentke, G. R., & Rich, D. H. (1998) · Journal of the American Chemical Society · doi:10.1021/ja981306x · Cited by 56
Stockwell, B. R., & Schreiber, S. L. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70299-4 · Cited by 54
Kopytek, S., Standaert, R. F., Dyer, J. C. D., & Hu, J. C. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00109-5 · Cited by 53
Bouras, A., Boggetto, N., Benatalah, Z., de Rosny, E., Sicsic, S., & Reboud‐Ravaux, M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9803976 · Cited by 51
Zewail, A. H. (2000) · Angewandte Chemie · doi:10.1002/1521-3757(20000804)112:15 · Cited by 50
The Inhibition of HIV-1 Protease by Interface Peptides
Schramm, H. J., Billich, A., Jaeger, E., RÜCKNAGEL, K. P., Arnold, G. J., & Schramm, W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1863 · Cited by 49
Cytokine receptor dimerization and activation: prospects for small molecule agonists
Boger, D. L., & Goldberg, J. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00276-5 · Cited by 47
Preißner, R., Goede, A., & Frömmel, C. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1878 · Cited by 42
Higher order iminodiacetic acid libraries for probing protein–protein interactions
Boger, D. L., Goldberg, J., Jiang, W., Chai, W., Ducray, P., Lee, J. K., Ozer, R. S., & Andersson, C. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00128-x · Cited by 40
Stickstoffmonoxid: ein einzigartiges endogenes Signalmolekül in der Gefäßbiologie (Nobel-Vortrag)
Ignarro, L. J. (1999) · Angewandte Chemie · doi:10.1002/(sici)1521-3757(19990712)111:13/14<2002::aid-ange2002>3.0.co;2-q · Cited by 40
Moss, N., Beaulieu, P. L., Duceppe, J., Ferland, J., Garneau, M., Gauthier, J. B., Ghiro, É., Goulet, S., Guse, I., Jaramillo, J., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960324r · Cited by 36
Structural basis of integrin-mediated signal transduction
Takada, Y., Kamata, T., Irie, A., Puzon-McLaughlin, W., & Zhang, X.-P. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90002-0 · Cited by 35
Moss, N., Déziel, R., Adams, J. D., Aubry, N., Bailey, M., Baillet, M., Beaulieu, P. L., DiMaio, J., & Duceppe, J. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00072a021 · Cited by 35
Myeong-cheol, S., Rajesh, S., Hayashi, Y., & Kiso, Y. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00468-1 · Cited by 35
Cited by
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
Thirumurugan, P., Matosiuk, D., & Jozwiak, K. (2013) · Chemical Reviews · doi:10.1021/cr200409f · Cited by 1,896
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705
“For these reasons, protein–protein interactions have been of great interest to drug discovery; however, developing small-molecule antagonists has been difficult (for recent reviews see Ref”
BackgroundPotential therapeutic applications of autophagy
Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O., & Klionsky, D. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2272 · Cited by 862
Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727
Small-Molecule Inhibition of TNF-α
He, M. M., Smith, A. S., Oslob, J. D., Flanagan, W. M., Braisted, A. C., Whitty, A., Cancilla, M. T., Wang, J., Lugovskoy, A. A., Yoburn, J. C., et al. (2005) · Science · doi:10.1126/science.1116304 · Cited by 620
Metadata
- Authors
- Berg, T.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2003-06-05
- Volume
- 42
- Issue
- 22
- Pages
- 2462-2481
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W1998492578
- Cited by
- 292
- References
- 212
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.